|
|
|
|
LEADER |
01984nam a22003495i 4500 |
001 |
978-1-4020-2804-5 |
005 |
20191026172416.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 ne | s |||| 0|eng d |
020 |
|
|
|a 9781402028045
|
024 |
7 |
|
|a 10.1007/1-4020-2804-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
100 |
1 |
|
|a Bodey, Bela.
|e author.
|
245 |
1 |
0 |
|a Molecular Markers of Brain Tumor Cells
|b Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy /
|c by Bela Bodey, Stuart E. Siegel, Hans E. Kaiser.
|
250 |
|
|
|a 1st ed. 2005.
|
260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2005.
|
300 |
|
|
|a XVII, 362 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Molecular Biology of Tumors -- Brain Tumors -- Immunophenotypic Characterization of Infiltrating Poly- and Mononuclear Cells in Childhood Brain Tumors -- Anti-Neoplastic Biological Therapies -- Experimental Therapies in Brain Tumors -- Biologic Anti-Neoplastic Therapies -- The Lymphokine Activeted Killer (LAK) Cell Phenomenon -- Angiogenesis Inhibition in Anti-Neoplastic Therapy -- Antigen Presentation by Dendritic Cells and Their Significance in Anti-Neoplastic Immunotherapy -- Genetically Engineered Antibodies for Direct Anti-Neoplastic Treatment and Systematic Delivery of Various Therapeutic Agents to Cancer Cells -- Cancer-Testis Antigens: Promising Targets for Antigen Directed Anti-Neoplastic Immunotherapy -- Prologue -- Materials and Methods.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Neurobiology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Neurobiology.
|
700 |
1 |
|
|a Siegel, Stuart E.
|e author.
|
700 |
1 |
|
|a Kaiser, Hans E.
|e author.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/1-4020-2804-0
|